San Diego Business Journal 's CFO of the Year Awards

Martha J. Demski Wins Community Service Award at the San Diego Business Journal's CFO of the Year Award Ceremony

March 19, 2014

Each year, the San Diego Business Journal recognizes Chief Financial Officers for the roles they play in the success of their businesses and their positive impact on the company. The CFOs are key professionals who exemplify hard work, dedication, ethics and the ability to inspire others to work together to find solutions to business challenges.

This year was the 8th Anniversary  of the event and we are proud to congratulate our Chief Financial Officer, Martha J. Demski for winning the Community Service Award.

Martha Demski has experienced incredible financial achievements, but what really sets her apart is her commitment to giving back to the community. Martha has proven that she believes in improving the lives of others, whether it is through mentoring her employees, helping businesses succeed, or promoting the innovation that has life-saving potential. Not only does this make her a wonderful person to know, but she also manifests these values in exceptional leadership that has driven Ajinomoto Althea Inc to increased financial success.

Biotech Innovation Recap: 2013 FDA Drug Approvals


fda approved

January 1, 2014

Before we get to work on all of our New Year's resolutions and plans for another successful year, lets take a moment and reflect upon the great strides our industry made in 2013.


Heartbreaking R&D Setbacks of the Year

December 16, 2013 

Even the hype surrounding the Biologics pipeline and Biotech IPO's can’t mask some of the most heartbreaking R&D setbacks of the year.


What's Been Trendy in Biotech: Top IPOs of the Year

December 11, 2013 

2012 barely saw a total of 10 IPO’s… and this year the list’s overflowing. A total of 39 Biotech companies went public this year, raising close to $3 billion. With the Biotech IPO frenzy that’s happened, compiling the top 10 has been a difficult task. So difficult that we’ve let FierceBiotech make the call. Making the list of the top Biotech IPO's this year are the following:


A Look at 2013's Biologics Pipeline

December 5, 2013 

As the end of the year approaches, let's take a look at what's been happening in the biologics pipeline. Not trying to age anyone out there, but doesn't it seem like just yesterday that we had figured out how to produce the first recombinant DNA drug product, with Eli Lilly's human insulin? And now we have close to 1000 biologic drugs in development this year alone! Let's take a look at what the folks in lab coats have been working on: